Congenital fibre type disproportion (CFTD) is so named because of the characteristic appearance of muscle fibres under a microscope. Muscle tissue has two different types of fibre, type 1 and type 2. In muscle of people affected by CFTD, type 1 fibres are smaller than type 2 fibres, and there are often more type 1 fibres than type 2 fibres. This results in generalised muscle weakness. Progression of CFTD is highly variable and is often determined by genetic background.
Support and Information
We are here for you and your family. For more information about fibre-tyoe disproportion or for support, contact our freephone support line or send us an email (Monday to Friday 8.30am - 6pm): 0800 652 6352 (freephone) email@example.com.
- Find a clinical trial See an overview of current clinical trials into muscle-wasting conditions in the UK and around the world
- Research we are funding See the current world-class pioneering research into potential treatments and cures that we are funding
- Publications Read our free publications including our expert factsheets about medical conditions and comprehensive guides on adapting your home
- Your stories Read about families and individuals who are affected by muscle-wasting conditions